Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (61-70 of 1,291) with videos related to

Pageof 130
Sort By:
Lancet (London, England)|August 12, 2018
Risankizumab for psoriasisAbigail Cline, Steven R Feldman
The Journal of Dermatological Treatment|July 9, 2009
Dermatological patient safety: problems and solutionsElizabeth Uhlenhake, Steven R Feldman
Dermatology Online Journal|April 22, 2009
Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasisPayman Kosari, Steven R Feldman
Dermatology Online Journal|May 8, 2012
Letter: Treatment-resistant pyoderma gangrenosumPayman Kosari, Steven R Feldman
Archives of Dermatology|November 21, 2012
Practice gap in patient education: comment on "the person-centered dermatology self-care index"Steven R Feldman, Laura Sandoval
Dermatology Online Journal|January 12, 2012
Letter: Tetracycline-induced hepatotoxicityCandace Glenn, Steven R Feldman
The Journal of Dermatological Treatment|September 30, 2020
Do increased risks of cancer mean we need to change our approach to treatment?Aditi Senthilnathan, Steven R Feldman
Pharmacology Research & Perspectives|August 17, 2023
Evaluating adverse events in databasesKatie Lovell, Steven R Feldman
The Journal of Dermatological Treatment|January 7, 2026
Are potential remittive properties of OX-40 inhibitors something to be excited about?Eliza Dewey, Steven R Feldman
Dermatology Online Journal|May 24, 2014
A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatologyFarah Moustafa, Steven R Feldman
Pageof 130

Showing results (61-70 of 1,291) with videos related to

Sort By:
Pageof 130
Lancet (London, England)|August 12, 2018
Risankizumab for psoriasisAbigail Cline, Steven R Feldman
The Journal of Dermatological Treatment|July 9, 2009
Dermatological patient safety: problems and solutionsElizabeth Uhlenhake, Steven R Feldman
Dermatology Online Journal|April 22, 2009
Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasisPayman Kosari, Steven R Feldman
Dermatology Online Journal|May 8, 2012
Letter: Treatment-resistant pyoderma gangrenosumPayman Kosari, Steven R Feldman
Archives of Dermatology|November 21, 2012
Practice gap in patient education: comment on "the person-centered dermatology self-care index"Steven R Feldman, Laura Sandoval
Dermatology Online Journal|January 12, 2012
Letter: Tetracycline-induced hepatotoxicityCandace Glenn, Steven R Feldman
The Journal of Dermatological Treatment|September 30, 2020
Do increased risks of cancer mean we need to change our approach to treatment?Aditi Senthilnathan, Steven R Feldman
Pharmacology Research & Perspectives|August 17, 2023
Evaluating adverse events in databasesKatie Lovell, Steven R Feldman
The Journal of Dermatological Treatment|January 7, 2026
Are potential remittive properties of OX-40 inhibitors something to be excited about?Eliza Dewey, Steven R Feldman
Dermatology Online Journal|May 24, 2014
A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatologyFarah Moustafa, Steven R Feldman
Pageof 130